Zynerba Pharmaceuticals R&D Expenses For Q3 Reach $5M, Here Are The Details
Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), released financial results for the third quarter ended September 30, 2022.
Q3 2022 Financial Highlights
Stocks That Hit 52-Week Lows On Monday
During Monday's session, 402 companies made new 52-week lows.
Cannabis Stock Gainers And Losers From September 21, 2022
GAINERS:
Icanic Brands (OTC:ICNAF) shares closed up 18.62% at $0.07
Cannabis Stock Gainers And Losers From September 20, 2022
GAINERS:
Item 9 Labs (OTC:INLB) shares closed up 8.89% at $0.49
Cannabis Stock Gainers And Losers From September 15, 2022
GAINERS:
iAnthus Capital Hldgs (OTC:ITHUF) shares closed up 5.70% at $0.06
LOSERS:
Bearish Sentiment Across The Cannabis Space – Check Full Movers For September 2, 2022
GAINERS:
Cipher Pharmaceuticals (OTC:CPHRF) shares closed up 6.60% at $2.10
Bearish Monday For Marijuana Stocks
GAINERS:
LOSERS:
Canopy Gwth (NASDAQ:CGC) shares closed down 13.61% at $3.30
Bearish Sentiment Across The Cannabis Space – Check Full Movers For August 19, 2022
GAINERS:
iAnthus Capital Hldgs (OTC:ITHUF) shares closed up 3.27% at $0.06